Medical News

RSS

Medgenics' EPODURE tissue Biopumps platform technology effective in maintaining hemoglobin levels

Medgenics is pleased to announce that one of the patients, who was treated with the Company’s EPODURE tissue Biopumps almost 11 months ago, continues to be effectively treated for anemia without a single erythropoietin (EPO) injection. This patient (#2) was dependent on frequent injections of the therapeutic protein (EPO) for the 18 months prior to receiving a single administration of 3 tiny EPODURE tissue Biopumps in the Company’s phase I/II anemia trial in Israel.

27 Aug 2009

URAC accredits Medversant in the 2009 CVO Standards category

Medversant Technologies (www.medversant.com), the nation’s exclusive provider of AutoVerifi™ technology (U.S. Patent 7,529,682) that continuously monitors Web-based credentials verification solutions for hospitals, health plans, state Medicaid programs, and other healthcare settings, has been accredited by the Utilization Review Accreditation Commission (URAC) in the 2009 Credentials Verification Organization (CVO) Standards category.

27 Aug 2009

Arrayit supplies instruments for identifying allergens

Arrayit Corporation, a proprietary life sciences technology leader, announces the sale of instruments used to identify allergens in affected individuals.

27 Aug 2009

Alegro Health renamed as Centric Health Corporation

Alegro Health Corp. (TSX-V: AGO), a provider of medical, surgical and rehabilitation and disability management services, today announced that it has changed its name to Centric Health Corporation. The Company received shareholder approval to change its name at a special meeting of shareholders held on August 25, 2009. The reason for the name change is that Management believes the new name better aligns the Company and brand with the industry in which it operates.

27 Aug 2009

First Edition: August 27, 2009

Today's news: Speculation begins regarding the impact Sen. Kennedy's death will have on the health reform debate and the Democrat's prospects for success.

27 Aug 2009

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Three out of four medical groups of Resurrection Health Care Preferred (RHCP) have earned nine blue stars, a perfect score, in the 2009 Blue Star Report -- an annual ranking of doctors in medical groups from Blue Cross Blue Shield of Illinois.

27 Aug 2009

Trident(R) donates proceeds for children's oral health

Trident(R), the best selling sugar-free gum brand in the world[4], is donating a portion of its proceeds during the first week in September to Smiles Across America(R) (SAA), the signature program of Oral Health America that supports dental services to thousands of children in underserved communities nationwide.

27 Aug 2009

MN Community Measurement publishes cost and quality information together to help consumers make informed decisions about their health care

In a significant step toward bringing cost and quality information together to help consumers make informed decisions about their health care, MN Community Measurement has published new information about how much medical groups are paid to provide more than 100 common health care services. MN Community Measurement, a nonprofit organization, already provides objective information on the quality of health care through its Web site, www.mnhealthscores.org.

27 Aug 2009

Waters exhibits the SYNAPT G2 system at the 18th International Mass Spectrometry Conference in Europe

Waters Corporation (NYSE: WAT) today exhibited for the first time in Europe the Waters((R)) SYNAPT(TM) G2 a system offering scientists greater power, versatility and speed at the 18(th) International Mass Spectrometry Conference (IMSC). Rounding out its display of mass spectrometry (MS) and UltraPerformance Liquid Chromatography (UPLC((R)))/MS systems at IMSC will be Waters Xevo(TM) family of tandem quadrupole and time-of-flight mass spectrometers noted for their ease-of-use and versatility.

27 Aug 2009

FDA approves clinical study of ATS 3f(R) Aortic Bioprosthesis with the younger aortic valve replacement population

ATS Medical, Inc. manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced today that the FDA has approved a landmark clinical study in which cardiac surgeons will implant the ATS 3f(R) Aortic Bioprosthesis in a younger aortic valve replacement patient population that has not been previously studied in a controlled and scientific manner.

27 Aug 2009

Department of Veterans Affairs cancels contract with UTSWMC for Gulf War research

Citing persistent noncompliance and numerous performance deficiencies, the Department of Veterans Affairs (VA) will not exercise the third year of a five-year, $75 million contract with the University of Texas Southwestern Medical Center (UTSWMC) to perform research into Gulf War Veterans' Illnesses (GWVI).

27 Aug 2009

Adventist Medical Center receives the Community Value Index Five-Star hospital award

Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC’s dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.

27 Aug 2009

Providing voluntary benefits to workers helps close financial gaps

Many employees now face gaps in coverage that put them at financial risk because of the economy, according to a new white paper released by Colonial Life.

27 Aug 2009

MMR Information Systems files Q2 2009 Form 10-Q for June 2009

MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), today announced that the Company has filed its second quarter Form10-Q for the period ended June 30, 2009 with the U.S. Securities and Exchange Commission.

27 Aug 2009

New analysis tool from Sg2 to help hospitals gear up for reform-driven payment changes

To help hospitals and health systems prepare for the impending payment changes associated with health care reform initiatives and a changing incentive structure, Sg2, a future-focused health care intelligence company, has released an innovative new tool -- the Sg2 Reform Readiness Analysis.

27 Aug 2009

New Associate Director of Business Development appointed by ERT

ERT, announced the appointment of a new Associate Director of Business Development - Japan, Miki Stevens. In this new role, Ms. Stevens will work with ERT's Japanese partner, Site Support Institute (SSI), to facilitate sales activities and to provide enhanced in-country support of Japanese sponsors and clinical trial sites.

27 Aug 2009

Bioreference Laboratories to issue earnings results for Q3 Fiscal Year 2009

BioReference Laboratories, Inc. announced today it plans to issue earnings results for the third quarter of fiscal 2009 before the open of market trading on Wednesday, September 2, 2009.

27 Aug 2009

oBand uses the da Vinci Surgical System to perform the world's first robotic surgery in an outpatient surgical center

oBand Surgery Centers, the nation's leading bariatric network of outpatient surgical facilities owned and operated by nationally recognized Lap Band surgeons, has set a new 'first' in the use of robotics for outpatient surgery. oBand Director of Robotic Surgery S. Adam Ramin, M.D., an assistant professor at City of Hope National Medical Center, today announced they have performed the world's first, outpatient robotic surgery using the famed da Vinci® Surgical System. Dr. Ramin performed the innovative surgery in July in Los Angeles using Robotics to remove a patient's pelvic cyst.

27 Aug 2009

Clinical data added to ORENCIA labeling help treat patients with rheumatoid arthritis

Bristol-Myers Squibb Company announced today that clinical data added to the labeling for ORENCIA (abatacept) support use of ORENCIA for patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration.

27 Aug 2009

Biotechnology Industry Organization mourns the death of Ted Kennedy

BIO joins the nation in mourning the loss of Senator Ted Kennedy. A dedicated public servant for more than four decades, Senator Kennedy was well-known for his leadership on health care issues in the Senate.

27 Aug 2009

Medical News

Medgenics' EPODURE tissue Biopumps platform technology effective in maintaining hemoglobin levels

URAC accredits Medversant in the 2009 CVO Standards category

Arrayit supplies instruments for identifying allergens

Alegro Health renamed as Centric Health Corporation

First Edition: August 27, 2009

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Trident(R) donates proceeds for children's oral health

MN Community Measurement publishes cost and quality information together to help consumers make informed decisions about their health care

Waters exhibits the SYNAPT G2 system at the 18th International Mass Spectrometry Conference in Europe

FDA approves clinical study of ATS 3f(R) Aortic Bioprosthesis with the younger aortic valve replacement population

Department of Veterans Affairs cancels contract with UTSWMC for Gulf War research

Adventist Medical Center receives the Community Value Index Five-Star hospital award

Providing voluntary benefits to workers helps close financial gaps

MMR Information Systems files Q2 2009 Form 10-Q for June 2009

New analysis tool from Sg2 to help hospitals gear up for reform-driven payment changes

New Associate Director of Business Development appointed by ERT

Bioreference Laboratories to issue earnings results for Q3 Fiscal Year 2009

oBand uses the da Vinci Surgical System to perform the world's first robotic surgery in an outpatient surgical center

Clinical data added to ORENCIA labeling help treat patients with rheumatoid arthritis

Biotechnology Industry Organization mourns the death of Ted Kennedy

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Latest News